On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayJul 07, 2017 12:28 pm

NetworkNewsBreaks – Digital Ally, Inc. (NASDAQ: DGLY) Shares Surge on U.S. Patent Office Denying Axon’s (NASDAQ: AAXN) Petition for IPR

Digital Ally (NASDAQ: DGLY) shares jumped 35% this morning after the company reported an important victory in its legal battles against Axon Enterprise, Inc. (NASDAQ: AAXN). The US Patent Office has denied Axon's petition for inter partes review (IPR) of Digital's 452 Patent, which covers the automatic activation and coordination of multiple recording devices in response to a triggering event such as a law enforcement officer activating the light bar on the vehicle. Not only was the IPR denied, the Patent Office also found that "...the information presented [by Axon] in the Petition does not establish a reasonable likelihood that…

Continue Reading

ThursdayJul 06, 2017 12:48 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on July 6, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ZYXI 19.35% – News: Pays entire remaining loan balance to Triumph Healthcare Finance UCLE 10.04% – News: Receives $722,500 contract with U.S. Air Force to supply portable Tritium air monitors MOMT 5.26% – News: Hosts conference call and webcast for fiscal year 2017 financial results RMGN 5.24% – News: Inks $530,000 contract with an existing customer in the Middle East DRWI 4.20% – News: Posting Q1 fiscal year 2018 results on July 12 KSHB…

Continue Reading

ThursdayJul 06, 2017 12:47 pm

NetworkNewsBreaks – MassRoots, Inc. (MSRT) Shares Rise on Acquisition of Odava Compliance Platform

MassRoots (OTCQB: MSRT) shares are up 8% mid-day on news that the company has entered a definitive agreement to acquire Odava, Inc. for cash and shares of MassRoots’ common stock. Odava is a platform technology company that delivers compliance, point-of-sale, and supply chain management to streamline business operations for the cannabis industry. "We expect with MassRoots' resources and relationships, we can grow the number of dispensaries utilizing Odava from dozens to hundreds by early next year. In the near future, we believe a significant percentage of all transactions occurring in the regulated cannabis industry will occur on our platform," MassRoots…

Continue Reading

ThursdayJul 06, 2017 11:51 am

NetworkNewsBreaks – Catalyst Biosciences, Inc. (NASDAQ: CBIO) Reaches Financial Milestone in Subcutaneous Factor IX Program

Catalyst Biosciences (NASDAQ: CBIO) reports that it has achieved a financial milestone under its collaboration with ISU Abxis following the enrollment of the first patient in its hemophilia B clinical trial. In June 2017, the first patient and cohort were enrolled in a phase 1/2 proof-of-concept clinical trial in individuals with severe hemophilia B to evaluate Catalyst’s next-generation Factor IX variant, CB 2679d/ISU304, for subcutaneous prophylaxis. ISU Abxis and Catalyst plan to have top-line data from the clinical trial by the end of 2017. “We are pleased to have achieved another financial milestone with the Factor IX clinical program, but…

Continue Reading

ThursdayJul 06, 2017 11:49 am

NetworkNewsBreaks – Cytori Therapeutics, Inc. (NASDAQ: CYTX) Shares Nudge Higher on New Key Cell Therapy Platform Patents

Cytori Therapeutics (NASDAQ: CYTX) this morning said it has received key patents that strengthen its intellectual property portfolio in the U.S. and Europe, sending shares up 2% mid-morning. To date, the company has 107 global patents issued in addition to 45 patent applications pending approval. Many of the most recently issued patents contain claims regarding the use of the company’s Habeo™ Cell Therapy for patients with scleroderma affecting the hands. "Our intellectual property strategy is to continue to strengthen the Cytori Cell Therapy™ platform to help establish and maintain a sustainable competitive advantage. Our main focus is on the primary…

Continue Reading

ThursdayJul 06, 2017 11:46 am

NetworkNewsBreaks – Moleculin Biotech, Inc. (NASDAQ: MBRX) Names Lead European Principal Investigator in Anticipated Annamycin Clinical Trial

Shares of Moleculin Biotech (NASDAQ: MBRX) are up 11% after the company named Dr. Lidia Gil of Poznan University of Medical Sciences in Poznan, Poland, as the lead European Principal Investigator for the upcoming planned phase I/II clinical trial of Annamycin for the treatment of relapsed or refractory acute myeloid leukemia (AML). The trial will commence if the company’s IND is permitted. "Dr. Gill is a dedicated investigator in AML and will bring significant expertise in the area as well as her potential to accelerate enrollment and the completion of our trial," Moleculin's chief medical officer, Dr. Robert Shepard, stated…

Continue Reading

ThursdayJul 06, 2017 10:21 am

NetworkNewsBreaks – ABcann Global Corporation (TSXV: ABCN) Included in the Horizons Medical Marijuana Life Sciences ETF

ABcann Global Corporation (TSXV: ABCN) yesterday announced its inclusion in the Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ). The ETF is a first-of-its-kind index offering investors direct exposure to a basket of North American life sciences companies with significant business activities in the medical marijuana sector. “The Horizons ETF represents a new type of investment, a fund that tracks an industry in which there is considerable interest but which had no prior investment vehicle through which investors could gain broad exposure,” Aaron Keay, CEO of ABcann, stated in the news release. “Our inclusion in the ETF represents an important…

Continue Reading

WednesdayJul 05, 2017 1:21 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on July 5, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: DCIX 372.29% – News: Settles $148M secured loan facility with RBS with payment of $85M NWGI 35.80% – News: Obtains required certification for betting software platform CERU 32.09% – News: Issues letter to stockholders CLSN 23.27% – News: Completes OVATION study; provides update on immunotherapy trial BLFS 10.43% – News: Reaches agreement to modify existing credit facility SWEE 8.33% – News: Receives GRAS confirmation from independent panel regarding BESTEVIA™ Reb-D MTBC 7.63% – News:…

Continue Reading

WednesdayJul 05, 2017 12:10 pm

NetworkNewsBreaks – Soleno Therapeutics, Inc. (NASDAQ: SLNO) Surges on Positive Guidance from FDA for DCCR in Prader-Willi Syndrome

Soleno Therapeutics (NASDAQ: SLNO) shares are up 11% on news that the company has received the minutes from a scientific advice meeting from the U.S. Food and Drug Administration (FDA) regarding Diazoxide Choline Controlled-Release (DCCR) for the treatment of Prader-Willi syndrome (PWS). The company previously submitted data from a phase II study of DCCR in PWS patients, as well as data from other studies conducted with DCCR. The company agreed with the FDA’s suggestion that the duration of the study should be shorter and that DCCR safety information could be obtained in a long-term, safety extension study. Soleno said it…

Continue Reading

WednesdayJul 05, 2017 12:07 pm

NetworkNewsBreaks – DryShips, Inc. (NASDAQ: DRYS) Takes Delivery of Its Second Modern Newcastlemax Vessel; Shares Higher

Shares of DryShips (NASDAQ: DRYS) are up 12% mid-day after the company earlier said it has taken delivery of its previously announced 205,123 DWT Newcastlemax drybulk vessel. The vessel, which is the second for the owner of ocean-going cargo vessels, was built in 2013. Per a previous agreement, the vessel will be employed under a time charter contract with a major coal and steel trader for a gross rate linked to the new Baltic Capesize Index (BCI5TC) plus 20%. To view the full press release, visit: http://nnw.fm/1v0SD About DryShips Inc. The company is a diversified owner of ocean going cargo…

Continue Reading

Contact us: 212.418.1217